Free Trial

California State Teachers Retirement System Has $46.30 Million Position in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

California State Teachers Retirement System lowered its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 1.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 399,078 shares of the industrial products company's stock after selling 6,809 shares during the period. California State Teachers Retirement System owned approximately 0.16% of Xylem worth $46,301,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Impax Asset Management Group plc lifted its holdings in shares of Xylem by 231.5% during the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock valued at $644,039,000 after purchasing an additional 3,883,845 shares in the last quarter. Norges Bank bought a new position in shares of Xylem during the 4th quarter valued at about $302,734,000. Northern Trust Corp lifted its holdings in shares of Xylem by 42.0% during the 4th quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock valued at $379,204,000 after purchasing an additional 966,399 shares in the last quarter. AMF Tjanstepension AB bought a new stake in Xylem in the 4th quarter valued at approximately $96,658,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Xylem in the 4th quarter valued at approximately $83,139,000. Institutional investors own 87.96% of the company's stock.

Xylem Stock Up 0.2%

Shares of NYSE:XYL traded up $0.29 during trading on Friday, hitting $125.95. 2,624,076 shares of the company were exchanged, compared to its average volume of 1,410,875. The stock has a market cap of $30.65 billion, a price-to-earnings ratio of 34.41, a P/E/G ratio of 2.33 and a beta of 1.10. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $143.50. The firm has a fifty day moving average price of $117.99 and a two-hundred day moving average price of $121.55. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.08. The firm had revenue of $2.07 billion for the quarter, compared to analyst estimates of $2.04 billion. Xylem had a return on equity of 9.96% and a net margin of 10.40%. The business's quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.90 EPS. As a group, research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Thursday, May 29th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date of this dividend is Thursday, May 29th. Xylem's payout ratio is presently 43.01%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on XYL shares. JPMorgan Chase & Co. started coverage on Xylem in a research note on Friday. They issued an "overweight" rating and a $148.00 target price on the stock. Royal Bank of Canada boosted their target price on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. Citigroup cut their target price on Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Robert W. Baird cut their target price on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 30th. Finally, Stifel Nicolaus boosted their target price on Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a research note on Wednesday, April 30th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, Xylem has a consensus rating of "Moderate Buy" and a consensus target price of $144.75.

Get Our Latest Stock Report on XYL

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines